[28th] Blood Cancer Know-it-Night: Announcement of "Pediatric Acute Leukemia" Seminar

Certified NPO CancerNet Japan will hold an online seminar "Blood Cancer Know-it-Night" on June 12, 2026, focusing on pediatric acute leukemia. This free event, open to patients, families, and healthcare professionals, aims to provide information on the advancements in blood cancer treatment.
イベントNQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 7, 2026 at 19:00
  • 🔍 Collected: April 7, 2026 at 10:31
  • 🤖 AI Analyzed: April 21, 2026 at 01:24 (326h 52m after Collected)

Certified NPO CancerNet Japan (Bunkyo Ward, Tokyo, Representative Director: Satoshi Iwase) has been holding monthly online seminars on blood cancer, "Blood Cancer Know-it-Night," since 2023. For its 28th session in June 2026, we are pleased to announce a seminar on the theme of "Pediatric Acute Leukemia." This seminar will be held utilizing a portion of the donations raised through our Lemonade Stand initiatives.

Participants can join from anywhere in Japan with an internet connection. The online seminar format, which allows participation even from hospital rooms, has been very well-received. Participation is free of charge.

[Event Outline]

■ Date and Time: June 12, 2026 (Friday) 19:00-21:00

■ Theme: Pediatric Acute Leukemia

■ Delivery Method: Online (Zoom Webinar)

Lecture (approx. 60 minutes) + Q&A (approx. 50 minutes) *Lecture portion will be archived and available at a later date.

■ Participation Fee: Free

■ Target Audience: Patients, their families, healthcare professionals, and anyone interested.

■ Registration: Required

■ Organizer: Certified NPO CancerNet Japan

■ Details: https://www.bloodcancerforum.jp/night/20260612

■ Registration Form: https://forms.gle/YgUAFzHNHoN7K4HC8

■ Overview:

The World of Pediatric Leukemia, Now Nearly 90% Curable

Pediatric leukemia, for which cure was once difficult to hope for until the 1960s, has now achieved a cure rate of nearly 90%. This has been accomplished through the accumulation of clinical trials conducted by multi-institutional collaborative research groups worldwide. The current research goal has shifted towards reducing treatment side effects and late complications without lowering the cure rate. To achieve this, cooperation among various medical departments, collaboration among multidisciplinary teams, and joint efforts with patient groups are essential.